Nuclear Medicine and Molecular Imaging

Aims & Scope

Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) is an official journal of the Korean Society of Nuclear Medicine, which bimonthly publishes papers on February, April, June, August, October, and December about nuclear medicine and related sciences such as radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy.

The journal will also welcome original works relating to molecular imaging research such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction.

Nucl Med Mol Imaging publishes the following types of papers: original articles, reviews, case reports, editorials, interesting images, and letters to the editor.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	1.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.517

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	35

Journal Rank

Year	Value
2024	11252

Journal Citation Indicator

Year	Value
2024	240

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Production of 177Lu for Targeted Radionuclide Therapy: Available Options

  Citation: 276

  Authors: Ashutosh, Maroor Raghavan Ambikalmajan, Furn F.

• Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

  Citation: 206

  Authors: Hyung-Jun, Tyler, Meiyappan, Steve Y.

• In Vivo Cell Tracking with Bioluminescence Imaging

  Citation: 138

  Authors: Jung Eun, Senthilkumar, Byeong-Cheol

• Radiomics in Oncological PET/CT: a Methodological Overview

  Citation: 98

  Authors: Seunggyun, Hongyoon, Jin Chul, Gi Jeong

• Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases

  Citation: 95

  Authors: Md. Maqusood, Jihye, Sang-Yoon

• Radiomics in Oncological PET/CT: Clinical Applications

  Citation: 87

  Authors: Jeong Won, Sang Mi

• Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology

  Citation: 83

  Authors: Muhammad Kashif, Sung Eun, Hyeongryul, Hyung Jun, Gi Jeong, Eun Seong, Keon Wook, Dong Soo

• Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept

  Citation: 78

  Authors: Richard P., Thomas, Aviral, Mostafa, Christiane, Gerd Fabian, Harshad

• Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies

  Citation: 75

  Authors: Ji Eun, Ho Sung

• Diagnostic Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT and 131I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma

  Citation: 66

  Authors: Teik Hin, Zanariah, Fathinul Fikri Ahmad, Ibrahim Lutfi

---